Postpartum Hemorrhage Clinical Trial
Official title:
Active Management of the Third Stage of Labour: Uterine Tonus Assessment by Midwife vs. Patient Self-administration
To determine whether there is a difference in effectiveness of routine uterine tonus assessment (every 15 minutes, for 2 hours) when performed by a midwife or self-administered by a patient on the incidence of postpartum haemorrhage, mean blood loss, and other maternal and neonatal outcomes.
Rationale: Postpartum haemorrhage (PPH) is the most common cause of maternal death
worldwide. The active management of the third stage of labour (AMTSL) is recognized as an
effective strategy to prevent morbidity and mortality associated with PPH and reduce blood
loss. AMTSL includes the provision of uterotonic drugs, controlled cord traction, delayed
cord clamping and cutting, massage of the uterus, and monitoring of the uterine tonus.
Although professional guidelines recommend the steps of AMTSL to be performed by health
professionals, the reality of health professionals understaffed hospitals in many low- and
middle income countries (LMICs) necessitates task-shifting of the final AMTSL component to
patients. Yet, whether uterine tonus assessment yields the same effect when performed by
patients and midwives has not been formally evaluated.
Objective: To determine whether there is a difference in effectiveness of routine uterine
tonus assessment (every 15 minutes, for 2 hours) when performed by a midwife or
self-administered by a patient on the incidence of postpartum haemorrhage . mean blood loss,
and other maternal and neonatal outcomes.
Study design: Randomized intervention study. Study population: Pregnant women admitted in
the labour to the Korle Bu Teaching Hospital, Accra, Ghana Intervention: the intervention
group will receive uterine tonus assessment every 15 minutes for 2 hours by a midwife, the
control group will continue the current practice of self-assessment after patient education
with regular monitoring of midwives.
Main study parameters/endpoints: post-partum haemorrhage (>500 ml blood loss), severe
postpartum haemorrhage (>1000 ml blood loss), mean blood loss, other maternal and neonatal
outcomes.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: Patients will receive the standard of midwifery and obstetric care, and will
have access to emergency obstetric interventions. All steps of the AMTSL will be performed,
with the exemption of the last step of uterine tonus assessment for which women will be
randomized to receive the intervention or current practice of care. Risk associated with the
intervention are discomfort because of an external assessment. Data will be obtained from
record books at the ward. Women will be asked for informed consent prior to participation.
This study will be approved by the Ethical en Protocol Review Committee of the University of
Ghana Medical School and the Medical Ethical Research Committee of the University Medical
Center Utrecht.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03434444 -
In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol
|
N/A | |
Terminated |
NCT01980173 -
Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care
|
N/A | |
Not yet recruiting |
NCT06033170 -
Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
|
N/A | |
Completed |
NCT02163616 -
Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study
|
Phase 3 | |
Not yet recruiting |
NCT02319707 -
Management of the Third Stage of Labor
|
Phase 3 | |
Recruiting |
NCT01600612 -
Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
|
N/A | |
Completed |
NCT02079558 -
Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
|
Phase 2 | |
Withdrawn |
NCT01108302 -
Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India
|
N/A | |
Completed |
NCT00097123 -
RCT of Misoprostol for Postpartum Hemorrhage in India
|
N/A | |
Completed |
NCT02883673 -
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
|
N/A | |
Completed |
NCT02542813 -
Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
|
Phase 1 | |
Completed |
NCT04201665 -
EMG for Uterotonic Efficiency Estimation
|
N/A | |
Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
Not yet recruiting |
NCT05501106 -
Reducing Postpartum Hemorrhage After Vaginal Delivery
|
N/A | |
Completed |
NCT05429580 -
Prophylactic Tranexamic Acid Use After Vaginal Delivery
|
N/A | |
Terminated |
NCT03064152 -
Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery
|
N/A | |
Recruiting |
NCT05382403 -
Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage
|
N/A | |
Not yet recruiting |
NCT02853552 -
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
|
Phase 4 | |
Completed |
NCT03344302 -
Oxytocin Administration During Cesarean Section
|
Phase 4 | |
Completed |
NCT02805426 -
Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage
|
Phase 4 |